David Einstein @davidjeinstein

Disease Group Leader, GU Medical Oncology @BIDMChealth @df_hcc, Asst Prof @harvardmed, dad, cyclist, Far Side superfan connects.catalyst.harvard.edu/Profiles/displ… Massachusetts, USA Joined January 2015

Tweets

950
Followers

730
Following

641
Likes

346

David Einstein @davidjeinstein

3 days ago

Love to see trials framed around Treatment-Free Survival!

Chad Tang, MD @ChadTangMD

3 days ago

Love to see trials framed around Treatment-Free Survival!

17 71 185 21K 37

Download Image

1 0 6 651 0

Ravi A Madan M.D. @Dr_RaviMadan

3 days ago

“The question is not should we or should we not stage using #PSMA-PET, but how to treat patients most properly using the information from a PSMA-PET,” said Thomas Hope, MD” @Medscape #ProstateCancer medscape.com/viewarticle/ps…

2 6 17 750 1

Download Image

Michael Serzan, MD @MikeSerzanMD

a month ago

⭐️ Giuseppe Carnevali Endowed Lecture ⭐️ “Unravelling the Mysteries of Kidney Cancer – A Journey from Genetics to Immunology” Dr. Samra Turajlic, MD @TheCrick A masterclass in Kidney Cancer from genetics 🧬 to immunogenicity 🦠to pearls that impact clinical care 🩺 !

0 3 11 1K 1

Download Image

David Einstein @davidjeinstein

a month ago

Patients with prostate cancer and their caretakers--join the Boston Prostate Cancer Support Group tonight, 6-8 pm EDT. bostonprostatecancer.org 6-7: Patient-led subgroups 7-8: @AtishChoudhury from @DanaFarber_GU speaks on emerging therapeutics!

0 2 3 364 0

Alexander Sherry @AlexSherryMD

a month ago

Does the addition of MDT to standard of care continuous ADT improve outcomes for oligomet prostate ca? Happy to share the results of EXTEND evaluating this question alongside PI @ChadTangMD & many others

5 79 185 23K 79

Download Image

Tyler Seibert MD PhD @TylerSbrt

2 months ago

Brief 🧵 1/ How common is *failure* of modern active surveillance (AS) for #ProstateCancer (PCa)? Which patients are at higher risk? Spoiler 🚨: it’s pretty simple @EurUrolOncol @urotoday @OncoAlert @PCF_Science @gu_onc @AmerUrological @Uroweb

6 56 130 16K 73

Download Image

OncLive.com @OncLive

2 months ago

👥 Connect, learn, & collaborate with your peers! Join Dr. Smith, Dr. Gao, @CaPsurvivorship, @davidjeinstein, @RickLee6 & @VincentWenxinXu at the Genitourinary Cancers State of the Science Summit on July 22! Register today: hubs.li/Q03wwJx20 @MGHCancerCenter #SOSSconnects

0 5 9 2K 0

Download Image

Ravi A Madan M.D. @Dr_RaviMadan

2 months ago

Do #PSMA+ findings in #BCR #ProstateCancer require immediate treatment? NO based on emerging data @theNCI Appreciate @TiansterZhang @urotoday for the opportunity to discuss Ongoing trial of PSMA scans in BCR is still enrolling: shorturl.at/36nGQ shorturl.at/FDFKl

1 5 11 716 1

David Einstein @davidjeinstein

2 months ago

Looking forward to this!

Uromigos @Uromigos

2 months ago

Looking forward to this!

0 16 45 4K 1

Download Image

0 0 1 174 0

David Einstein @davidjeinstein

2 months ago

Nothing says relaxing immersion like Radium

0 0 3 222 0

Download Image

David Einstein @davidjeinstein

2 months ago

How should patients think about tough treatment decisions for biochemically recurrent prostate cancer? @BIDMC_HOFellows Lauren O'Loughlin shows how we talk about BCR in our clinic for @urotoday. urotoday.com/recent-abstrac…

0 1 5 667 0

David Einstein @davidjeinstein

3 months ago

Very important risk-adapted study!

Zach Klaassen @zklaassen_md

3 months ago

Very important risk-adapted study!

2 18 32 3K 5

Download Image

1 0 3 180 0

Ravi A Madan M.D. @Dr_RaviMadan

3 months ago

What should we do for #ProstateCancer patients with #PSMA+ #BCR? While we can use any treatment do we NEED to? Stop by tomorrow abstract BD# 297. Monday 9am-noon The answer is pretty clear… #ASCO25 @ASCO @theNCI

Ravi A Madan M.D. @Dr_RaviMadan

3 months ago

1 9 17 6K 1

Download Image

1 5 9 1K 1

Download Image

David Einstein @davidjeinstein

4 months ago

Massachusetts Prostate Cancer Coalition annual virtual symposium starting in 1 hour! masspcc.org/events/

0 1 2 549 0

Dana-Farber Lank Center for Genitourinary Oncology @DanaFarber_GU

5 months ago

This summer: @OncLive State of the Science Summit on GU malignancies. Collaborative across Dana-Farber/Harvard Cancer Center programs, featuring from the Lank Center @CaPsurvivorship on prostate cancer and @VincentWenxinXu on kidney cancer. More info in the flyer below 👇

0 9 21 2K 1

Download Image

Mark C. Markowski @MarkowskiGUOnc

9 months ago

Your natural history study with PSMA PET imaging will be incredibly important. We did not find an association between PSADT and a positive PSMA PET. To me this suggests that novel imaging may not inform who needs treatment. PSADT still the gold standard.